Dermata Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 178.9%.

Top 16 shareholders own 11.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.19%	Armistice Capital LLC	412,111	US$141.2k	0%	no data
2.97%	Gerald Proehl	198,152	US$67.9k	0%	no data
0.83%	Acadian Asset Management LLC	55,179	US$18.9k	-27%	no data
0.5%	Hale BioPharma Ventures LLC	33,307	US$11.4k	0%	no data
0.2%	Virtu Financial LLC, Asset Management Arm	13,500	US$4.6k	0%	no data
0.18%	Geode Capital Management, LLC	12,237	US$4.2k	0%	no data
0.12%	David Hale	7,726	US$2.6k	0%	no data
0.096%	Tower Research Capital LLC	6,420	US$2.2k	24.9%	no data
0.059%	Wendell Wierenga	3,899	US$1.3k	0%	no data
0.028%	Kathleen Scott	1,848	US$633.2	0%	no data
0.026%	Christopher Nardo	1,722	US$590.1	0%	no data
0.023%	Andrew Sandler	1,511	US$517.7	0%	no data
0.022%	Mary Fisher	1,465	US$502.0	0%	no data
0.022%	Brittany Bradrick	1,465	US$502.0	0%	no data
0.01%	Wells Fargo & Company, Securities and Brokerage Investments	687	US$235.3	0%	no data
0.00024%	Wells Fargo & Company, Private Banking and Investment Banking Arm	16	US$5.5	6.67%	no data